Literature DB >> 31517882

Burden of Sciatica on US Medicare Recipients.

Joseph P Maslak1, Tyler J Jenkins, Joseph A Weiner, Abhishek S Kannan, Daneel M Patoli, Michael H McCarthy, Wellington K Hsu, Alpesh A Patel.   

Abstract

OBJECTIVE: This study evaluates the disease burden of sciatica on the US Medicare cohort. BACKGROUND DATA: Sciatica is a common disability that has important physical, mental, and economic effects. The Medicare Health Outcomes Survey (HOS) is a demographic and outcomes survey used to monitor the performance of Medicare Advantage health plans in the United States. The HOS includes data on demographics, chronic medical conditions, and patient-reported outcomes.
METHODS: Medicare HOS data for cohorts from 2007 to 2013 were obtained. Patients were placed into two categories based on the survey results: with or without a history of sciatica. Baseline demographics, chronic medical conditions, and physical health symptoms were aggregated. In addition, average VR-12 physical component summary and mental component summary scores were calculated for each group at baseline and at 2-year follow-up. A Fisher exact test was used to assess significance for categorical variables, and a t-test was used for continuous variables. VR-12 changes as small as 1 to 2 units have been found to be clinically and socially relevant.
RESULTS: The baseline cohort data of 1,000,952 patients yielded 250,869 patients (25%) who reported the diagnosis of sciatica, compared with 750,083 patients (75%) without sciatica. Patients with a history of sciatica tended to be younger, less educated, and notably with more medical comorbidities. Physical component summary outcomes were approximately 8 units lower in the sciatica group at baseline and 7 units lower at 2-year follow-up. Mental component summary outcomes were 6 units lower in the sciatica group at baseline and 5 units lower at 2-year follow-up.
CONCLUSION: A large percentage of the US Medicare cohort suffers from symptomatic sciatica. Our study identified a 25% prevalence in the Medicare cohort. In addition, sciatica is associated with an increased incidence of comorbid medical conditions and poor health-related quality of life. LEVEL OF EVIDENCE: Level III STUDY
DESIGN: : Observational-Cohort Study.

Entities:  

Year:  2020        PMID: 31517882     DOI: 10.5435/JAAOS-D-19-00174

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  3 in total

1.  OASIS-a randomised, placebo-controlled trial of oral glucocorticoids for leg pain in patients with acute sciatica: trial protocol.

Authors:  Chang Liu; Christina Abdel Shaheed; Andrew J McLachlan; Jane Latimer; Qiang Li; Rachelle Buchbinder; Richard O Day; Christopher G Maher; Bethan Richards; Juliana S Oliveira; Chung-Wei Christine Lin
Journal:  BMJ Open       Date:  2020-06-23       Impact factor: 2.692

2.  Acupoint catgut embedding for the treatment of sciatica: A protocol for a systematic review.

Authors:  Yingrong Zhang; Yanji Zhang; Xia Chen; Kou Xu; Mengyuan Huang; Sanchun Tan; Zhongyu Zhou
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

3.  Cost-effectiveness of full endoscopic versus open discectomy for sciatica.

Authors:  Pravesh Shankar Gadjradj; Hana M Broulikova; Johanna M van Dongen; Sidney M Rubinstein; Paul R Depauw; Carmen Vleggeert; Ankie Seiger; Wilco C Peul; Job L van Susante; Maurits W van Tulder; Biswadjiet S Harhangi
Journal:  Br J Sports Med       Date:  2022-02-20       Impact factor: 18.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.